Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Postpartum anti-D immunoglobulin prophylaxis in Rh-negative women
RBR-27sdv5Phase 3Recruiting
- Sponsor
- Hospital São Lucas da PUCRS
- Start
- Feb 2013
- Modality
- Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of rho(d) immune globulin in Erythroblastosis fetalis (HDFN), sponsored by Hospital São Lucas da PUCRS. Primary endpoint: Clinical status and immunization monitoring. Started Feb 2013; status: recruiting.
02
Drugs
rho(d) immune globulin
03
Conditions
Erythroblastosis fetalis (HDFN)
Beyond the preview
Go deeper on RBR-27sdv5.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-27sdv5.